BIOFILM-RESPONSIVE PRODRUG DESIGN: AN EMERGING MEDICINAL CHEMISTRY STRATEGY AGAINST ANTIMICROBIAL RESISTANCE

Read full text Summarise with VIRAT
Authors: Pashayeva A., Kazimova G.
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antimicrobial resistance remains one of the most serious threats to global health, and biofilm-associated infections represent one of its most therapeutically resistant manifestations. Conventional antibiotics are commonly optimized against planktonic bacteria, yet their clinical performance often decreases in mature biofilms because of poor penetration, altered microenvironmental conditions, metabolic heterogeneity, and the presence of tolerant subpopulations. In response to these limitations, medicinal chemistry is increasingly shifting from the design of broadly active antibacterial agents toward the development of context-dependent systems capable of selective activation at the site of infection. One of the most promising directions in this regard is biofilm-responsive prodrug design. This article reviews the medicinal chemistry rationale behind prodrugs that remain relatively stable during systemic transport but undergo activation in biofilm-specific microenvironments. Particular attention is paid to pH-responsive, enzyme-responsive, redox-responsive, and metabolite-guided activation mechanisms, as well as to the role of linker engineering, physicochemical optimization, and release kinetics in achieving effective antibacterial action. The paper also examines the potential of multifunctional designs that combine antibiotic release with antibiofilm, quorum-sensing-interfering, or antivirulence effects. In addition, key translational barriers are analyzed, including biofilm heterogeneity, insufficient predictive screening models, safety concerns, and regulatory complexity. It is argued that biofilm-responsive prodrugs may redefine anti-infective medicinal chemistry by integrating drug transport, site-selective activation, and microenvironment-aware therapeutic action into a single molecular strategy

Fields of Study & Subjects

Bacterial biofilms and quorum sensing Antimicrobial agents and applications Advanced Drug Delivery Systems

Publication details

Journal / source
Sciences of Europe
Publication date
30 March 2026
Language
EN